Introduction to hyperthermia device evaluation.

Area of Science:

• Oncology
• Biomedical Engineering
• Medical Physics

Background:

• The National Cancer Institute (NCI) initiated a comprehensive evaluation of hyperthermia technologies for cancer treatment.
• Data from 1981-1986 were compiled into a consensus database from four participating institutions.
• The study encompassed 792 treatment sites across 573 patients receiving hyperthermia therapy.

Purpose of the Study:

• To assess the efficacy and characteristics of various hyperthermia devices.
• To establish a standardized evaluation methodology for hyperthermia technology.
• To provide a foundational report for a series on hyperthermia device evaluation.

Main Methods:

• Evaluation of 49 distinct hyperthermia devices, including ultrasound (US), magnetic induction (MI), radiative electromagnetic (EM), and interstitial (IRF) modalities.
• Data collection across 792 treatment sites in 573 patients over a five-year period (1981-1986).
• Analysis of device performance and application across different treatment sites, with some sites receiving multiple modalities.

Main Results:

• A wide array of 49 devices were tested, categorized into US (16 devices, 195 sites), MI (9 devices, 208 sites), EM (20 devices, 488 sites), and IRF (4 devices, 37 sites).
• The majority of evaluated sites (488) utilized radiative electromagnetic devices.
• Multiple hyperthermia modalities were employed in numerous treatment sites, indicating a complex treatment landscape.

Conclusions:

• The study successfully established a framework for evaluating diverse hyperthermia devices.
• The collected data represents a significant resource for understanding the application of various hyperthermia technologies in cancer treatment.
• This report serves as an introduction to a larger series detailing the findings of the Contractors' Group on hyperthermia device evaluation.